NCT06289504 A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight Status COMPLETED Phase PHASE1
NCT06283667 Special Use - Results Surveillance on Long-term Use With Wegovy® Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06282458 Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt Status COMPLETED Phase PHASE2
NCT06260722 Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06256549 A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06243536 The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients Status NOT_YET_RECRUITING Phase PHASE4
NCT06222437 Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy Status WITHDRAWN Phase PHASE1
NCT06221969 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor Status COMPLETED Phase PHASE3
NCT06207877 A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight Status COMPLETED Phase PHASE1
NCT06184568 A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity Status COMPLETED Phase PHASE3
NCT06131437 A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight Status COMPLETED Phase PHASE3
NCT06131372 A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo Status COMPLETED Phase PHASE2
NCT06097390 A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III Status COMPLETED Phase PHASE1
NCT06083675 Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes Status WITHDRAWN Phase PHASE3
NCT06082063 Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes Status RECRUITING Phase PHASE3
NCT06065540 A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor Status COMPLETED Phase PHASE3
NCT06045221 A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin Status COMPLETED Phase PHASE3